US · biotech · health · longevity
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Seed · Oct 2025 · $1.2M
Alex Zhavoronkov, Early Game Ventures, Portfolia’s Active Aging & Longevity Fund II, Sonia Arrison’s 100 Plus Capital, syndicated angel SPV
Reported by TechStartups
Missing a round, or an investor who was in one? Tell us.